These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11835679)

  • 1. Delayed chromosome changes in gamma-irradiated normal and Li-Fraumeni fibroblasts.
    Boyle JM; Spreadborough AR; Greaves MJ; Birch JM; Varley JM; Scott D
    Radiat Res; 2002 Feb; 157(2):158-65. PubMed ID: 11835679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.
    Burt EC; James LA; Greaves MJ; Birch JM; Boyle JM; Varley JM
    Br J Cancer; 2000 Aug; 83(4):467-72. PubMed ID: 10945493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G2 chromosomal radiosensitivity in fibroblasts of ataxia-telangiectasia heterozygotes and a Li-Fraumeni syndrome patient with radioresistant cells.
    Mitchell EL; Scott D
    Int J Radiat Biol; 1997 Oct; 72(4):435-8. PubMed ID: 9343108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.
    Boyle JM; Mitchell EL; Greaves MJ; Roberts SA; Tricker K; Burt E; Varley JM; Birch JM; Scott D
    Br J Cancer; 1998 Jun; 77(12):2181-92. PubMed ID: 9649131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations.
    Boyle JM; Spreadborough A; Greaves MJ; Birch JM; Varley JM; Scott D
    Br J Cancer; 2001 Jul; 85(2):293-6. PubMed ID: 11461092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation.
    Tsutsui T; Tanaka Y; Matsudo Y; Hasegawa K; Fujino T; Kodama S; Barrett JC
    Mol Carcinog; 1997 Jan; 18(1):7-18. PubMed ID: 9022808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome instability in fibroblasts derived from Li-Fraumeni syndrome families without TP53 mutations.
    Boyle JM; Spreadborough A; Greaves MJ; Birch JM; Scott D
    Br J Cancer; 2000 Nov; 83(9):1136-8. PubMed ID: 11027425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblasts from Li-Fraumeni patients are resistant to low dose-rate irradiation.
    Sproston AR; Boyle JM; Heighway J; Birch JM; Scott D
    Int J Radiat Biol; 1996 Aug; 70(2):145-50. PubMed ID: 8794843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations.
    Boyle JM; Greaves MJ; Camplejohn RS; Birch JM; Roberts SA; Varley JM
    Br J Cancer; 1999 Apr; 79(11-12):1657-64. PubMed ID: 10206274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?
    Williams KJ; Boyle JM; Birch JM; Norton JD; Scott D
    Oncogene; 1997 Jan; 14(3):277-82. PubMed ID: 9018113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.
    Ford JM; Hanawalt PC
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8876-80. PubMed ID: 7568035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faulty DNA polymerase delta/epsilon-mediated excision repair in response to gamma radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.
    Mirzayans R; Enns L; Dietrich K; Barley RD; Paterson MC
    Carcinogenesis; 1996 Apr; 17(4):691-8. PubMed ID: 8625479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.
    Mirzayans R; Aubin RA; Bosnich W; Blattner WA; Paterson MC
    Br J Cancer; 1995 Jun; 71(6):1221-30. PubMed ID: 7779715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
    Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
    Mirzayans R; Severin D; Murray D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage.
    De Moura J; Kavalec FL; Doghman M; Rosati R; Custodio G; Lalli E; Cavallari GM; Santa Maria J; Figueiredo BC
    Int J Oncol; 2010 Apr; 36(4):983-90. PubMed ID: 20198344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.